AMY HOFFMAN: Open Payments
NPI 1053751461 · MIDDLEBURY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$239 in 12 payments from 8 companies in 2025. Trend: 2023 $197 · 2024 $433 · 2025 $239
Food & beverage: $239
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 3 | $58 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| ABBVIE INC. | 2 | $40 |
| Tris Pharma Inc | 1 | $22 |
| Lilly USA, LLC | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Exact Sciences Corporation | 1 | $20 |
| PFIZER INC. | 1 | $16 |
Products named: Qelbree, Auvelity, QULIPTA, Dyanavel XR, MOUNJARO, PENMENVY, Cologuard Collection Kit, VRAYLAR.
Industry payments across IN — which companies pay providers there.
